Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer

• Status: Completed
• Trial end date: 2009-07-01

Summary

This study will evaluate the toxicity and secondary the efficacy of the combination vinorelbine plus capecitabine in metastatic breast cancer patients

• Phase: Phase 1

Details

• Lead Sponsor: Hellenic Oncology Research Group
• Collaborator: University Hospital of Crete
• Treatments: Capecitabine; Vinblastine; Vinorelbine